These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum. Lukacova S; Khalil AA; Overgaard J; Alsner J; Horsman MR Int J Radiat Biol; 2005 Dec; 81(12):937-44. PubMed ID: 16524849 [TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis. Sakata M; Tsuruha JI; Masuko-Hongo K; Nakamura H; Matsui T; Sudo A; Nishioka K; Kato T J Rheumatol; 2001 Jul; 28(7):1492-5. PubMed ID: 11469452 [TBL] [Abstract][Full Text] [Related]
26. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma. Wong TS; Kwong DL; Sham J; Wei WI; Kwong YL; Yuen AP Eur J Surg Oncol; 2005 Jun; 31(5):555-8. PubMed ID: 15922893 [TBL] [Abstract][Full Text] [Related]
27. Receptor activator of NF(Kappa)B ligand/osteoprotegerin (RANKL/OPG) system and osteopontin (OPN) serum levels in a population of apulian postmenopausal women. D'Amore M; Fanelli M; D'Amore S; Fontana A; Minenna G Panminerva Med; 2006 Dec; 48(4):215-21. PubMed ID: 17215793 [TBL] [Abstract][Full Text] [Related]
28. Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis. Inomata S; Shijubo N; Kon S; Maeda M; Yamada G; Sato N; Abe S; Uede T Cytokine; 2005 May; 30(4):203-11. PubMed ID: 15863395 [TBL] [Abstract][Full Text] [Related]
29. The functional and clinical roles of osteopontin in cancer and metastasis. Furger KA; Menon RK; Tuck AB; Bramwell VH; Chambers AF Curr Mol Med; 2001 Nov; 1(5):621-32. PubMed ID: 11899236 [TBL] [Abstract][Full Text] [Related]
30. Polycystic ovary syndrome is associated with increased osteopontin levels. Saklamaz A; Calan M; Yilmaz O; Kume T; Temur M; Yildiz N; Kasap E; Genc M; Sarer Yurekli B; Unal Kocabas G Eur J Endocrinol; 2016 Apr; 174(4):415-23. PubMed ID: 26701868 [TBL] [Abstract][Full Text] [Related]
31. A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients. Leslie A; Teh E; Druker A; Pinto DM PLoS One; 2023; 18(6):e0281491. PubMed ID: 37384615 [TBL] [Abstract][Full Text] [Related]
32. Elevated osteopontin levels in active relapsing-remitting multiple sclerosis. Vogt MH; Lopatinskaya L; Smits M; Polman CH; Nagelkerken L Ann Neurol; 2003 Jun; 53(6):819-22. PubMed ID: 12783433 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Koopmann J; Fedarko NS; Jain A; Maitra A; Iacobuzio-Donahue C; Rahman A; Hruban RH; Yeo CJ; Goggins M Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):487-91. PubMed ID: 15006928 [TBL] [Abstract][Full Text] [Related]
35. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Koguchi Y; Kawakami K; Uezu K; Fukushima K; Kon S; Maeda M; Nakamoto A; Owan I; Kuba M; Kudeken N; Azuma M; Yara S; Shinzato T; Higa F; Tateyama M; Kadota J; Mukae H; Kohno S; Uede T; Saito A Am J Respir Crit Care Med; 2003 May; 167(10):1355-9. PubMed ID: 12574077 [TBL] [Abstract][Full Text] [Related]
36. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Ohmori R; Momiyama Y; Taniguchi H; Takahashi R; Kusuhara M; Nakamura H; Ohsuzu F Atherosclerosis; 2003 Oct; 170(2):333-7. PubMed ID: 14612215 [TBL] [Abstract][Full Text] [Related]
37. Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Sennels HP; Jacobsen S; Jensen T; Hansen MS; Ostergaard M; Nielsen HJ; Sørensen S Scand J Clin Lab Invest; 2007; 67(8):821-35. PubMed ID: 17852826 [TBL] [Abstract][Full Text] [Related]
39. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer. Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456 [TBL] [Abstract][Full Text] [Related]